Literature DB >> 21454522

Discovery of a novel site regulating glucokinase activity following characterization of a new mutation causing hyperinsulinemic hypoglycemia in humans.

Nicola L Beer1, Martijn van de Bunt, Kevin Colclough, Christine Lukacs, Paul Arundel, Constance L Chik, Joseph Grimsby, Sian Ellard, Anna L Gloyn.   

Abstract

Type 2 diabetes is a global problem, and current ineffective therapeutic strategies pave the way for novel treatments like small molecular activators targeting glucokinase (GCK). GCK activity is fundamental to beta cell and hepatocyte glucose metabolism, and heterozygous activating and inactivating GCK mutations cause hyperinsulinemic hypoglycemia (HH) and maturity onset diabetes of the young (MODY) respectively. Over 600 naturally occurring inactivating mutations have been reported, whereas only 13 activating mutations are documented to date. We report two novel GCK HH mutations (V389L and T103S) at residues where MODY mutations also occur (V389D and T103I). Using recombinant proteins with in vitro assays, we demonstrated that both HH mutants had a greater relative activity index than wild type (6.0 for V389L, 8.4 for T103S, and 1.0 for wild type). This was driven by an increased affinity for glucose (S(0.5), 3.3 ± 0.1 and 3.5 ± 0.1 mm, respectively) versus wild type (7.5 ± 0.1 mm). Correspondingly, the V389D and T103I MODY mutants had markedly reduced relative activity indexes (<0.1). T103I had an altered affinity for glucose (S(0.5), 24.9 ± 0.6 mm), whereas V389D also exhibited a reduced affinity for ATP and decreased catalysis rate (S(0.5), 78.6 ± 4.5 mm; ATP(K(m)), 1.5 ± 0.1 mm; K(cat), 10.3 ± 1.1s(-1)) compared with wild type (ATP(K(m)), 0.4 ± <0.1; K(cat), 62.9 ± 1.2). Both Thr-103 mutants showed reduced inhibition by the endogenous hepatic inhibitor glucokinase regulatory protein. Molecular modeling demonstrated that Thr-103 maps to the allosteric activator site, whereas Val-389 is located remotely to this position and all other previously reported activating mutations, highlighting α-helix 11 as a novel region regulating GCK activity. Our data suggest that pharmacological manipulation of GCK activity at locations distal from the allosteric activator site is possible.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454522      PMCID: PMC3099725          DOI: 10.1074/jbc.M111.223362

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  Cell-biological assessment of human glucokinase mutants causing maturity-onset diabetes of the young type 2 (MODY-2) or glucokinase-linked hyperinsulinaemia (GK-HI).

Authors:  C V Burke; C W Buettger; E A Davis; S J McClane; F M Matschinsky; S E Raper
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

2.  Characterization of glucokinase-binding protein epitopes by a phage-displayed peptide library. Identification of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as a novel interaction partner.

Authors:  S Baltrusch; S Lenzen; D A Okar; A J Lange; M Tiedge
Journal:  J Biol Chem       Date:  2001-08-24       Impact factor: 5.157

3.  Glucokinase activators (GKAs) promise a new pharmacotherapy for diabetics.

Authors:  Franz M Matschinsky; Daniel Porte
Journal:  F1000 Med Rep       Date:  2010-06-16

4.  Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation.

Authors:  Antonio L Cuesta-Muñoz; Hanna Huopio; Timo Otonkoski; Juan M Gomez-Zumaquero; Kirsti Näntö-Salonen; Jacques Rahier; Soledad López-Enriquez; Maria A García-Gimeno; Pascual Sanz; Federico C Soriguer; Markku Laakso
Journal:  Diabetes       Date:  2004-08       Impact factor: 9.461

5.  Permanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation: initial response to oral sulphonylurea therapy.

Authors:  Doga Turkkahraman; Iffet Bircan; Nicholas D Tribble; Sema Akçurin; Sian Ellard; Anna L Gloyn
Journal:  J Pediatr       Date:  2008-03-06       Impact factor: 4.406

6.  Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations.

Authors:  Anna L Gloyn; Kees Noordam; Michèl A A P Willemsen; Sian Ellard; Wayne W K Lam; Ian W Campbell; Paula Midgley; Chyio Shiota; Carol Buettger; Mark A Magnuson; Franz M Matschinsky; Andrew T Hattersley
Journal:  Diabetes       Date:  2003-09       Impact factor: 9.461

7.  Allosteric activation of human glucokinase by free polyubiquitin chains and its ubiquitin-dependent cotranslational proteasomal degradation.

Authors:  Lise Bjørkhaug; Janne Molnes; Oddmund Søvik; Pål Rasmus Njølstad; Torgeir Flatmark
Journal:  J Biol Chem       Date:  2007-06-08       Impact factor: 5.157

8.  Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase.

Authors:  Kenji Kamata; Morihiro Mitsuya; Teruyuki Nishimura; Jun-Ichi Eiki; Yasufumi Nagata
Journal:  Structure       Date:  2004-03       Impact factor: 5.006

9.  A common haplotype of the glucokinase gene alters fasting glucose and birth weight: association in six studies and population-genetics analyses.

Authors:  Michael N Weedon; Vanessa J Clark; Yudong Qian; Yoav Ben-Shlomo; Nicholas Timpson; Shah Ebrahim; Debbie A Lawlor; Marcus E Pembrey; Susan Ring; Terry J Wilkin; Linda D Voss; Alison N Jeffery; Brad Metcalf; Luigi Ferrucci; Anna Maria Corsi; Anna Murray; David Melzer; Bridget Knight; Bev Shields; George Davey Smith; Andrew T Hattersley; Anna Di Rienzo; Tim M Frayling
Journal:  Am J Hum Genet       Date:  2006-10-06       Impact factor: 11.025

10.  New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.

Authors:  Josée Dupuis; Claudia Langenberg; Inga Prokopenko; Richa Saxena; Nicole Soranzo; Anne U Jackson; Eleanor Wheeler; Nicole L Glazer; Nabila Bouatia-Naji; Anna L Gloyn; Cecilia M Lindgren; Reedik Mägi; Andrew P Morris; Joshua Randall; Toby Johnson; Paul Elliott; Denis Rybin; Gudmar Thorleifsson; Valgerdur Steinthorsdottir; Peter Henneman; Harald Grallert; Abbas Dehghan; Jouke Jan Hottenga; Christopher S Franklin; Pau Navarro; Kijoung Song; Anuj Goel; John R B Perry; Josephine M Egan; Taina Lajunen; Niels Grarup; Thomas Sparsø; Alex Doney; Benjamin F Voight; Heather M Stringham; Man Li; Stavroula Kanoni; Peter Shrader; Christine Cavalcanti-Proença; Meena Kumari; Lu Qi; Nicholas J Timpson; Christian Gieger; Carina Zabena; Ghislain Rocheleau; Erik Ingelsson; Ping An; Jeffrey O'Connell; Jian'an Luan; Amanda Elliott; Steven A McCarroll; Felicity Payne; Rosa Maria Roccasecca; François Pattou; Praveen Sethupathy; Kristin Ardlie; Yavuz Ariyurek; Beverley Balkau; Philip Barter; John P Beilby; Yoav Ben-Shlomo; Rafn Benediktsson; Amanda J Bennett; Sven Bergmann; Murielle Bochud; Eric Boerwinkle; Amélie Bonnefond; Lori L Bonnycastle; Knut Borch-Johnsen; Yvonne Böttcher; Eric Brunner; Suzannah J Bumpstead; Guillaume Charpentier; Yii-Der Ida Chen; Peter Chines; Robert Clarke; Lachlan J M Coin; Matthew N Cooper; Marilyn Cornelis; Gabe Crawford; Laura Crisponi; Ian N M Day; Eco J C de Geus; Jerome Delplanque; Christian Dina; Michael R Erdos; Annette C Fedson; Antje Fischer-Rosinsky; Nita G Forouhi; Caroline S Fox; Rune Frants; Maria Grazia Franzosi; Pilar Galan; Mark O Goodarzi; Jürgen Graessler; Christopher J Groves; Scott Grundy; Rhian Gwilliam; Ulf Gyllensten; Samy Hadjadj; Göran Hallmans; Naomi Hammond; Xijing Han; Anna-Liisa Hartikainen; Neelam Hassanali; Caroline Hayward; Simon C Heath; Serge Hercberg; Christian Herder; Andrew A Hicks; David R Hillman; Aroon D Hingorani; Albert Hofman; Jennie Hui; Joe Hung; Bo Isomaa; Paul R V Johnson; Torben Jørgensen; Antti Jula; Marika Kaakinen; Jaakko Kaprio; Y Antero Kesaniemi; Mika Kivimaki; Beatrice Knight; Seppo Koskinen; Peter Kovacs; Kirsten Ohm Kyvik; G Mark Lathrop; Debbie A Lawlor; Olivier Le Bacquer; Cécile Lecoeur; Yun Li; Valeriya Lyssenko; Robert Mahley; Massimo Mangino; Alisa K Manning; María Teresa Martínez-Larrad; Jarred B McAteer; Laura J McCulloch; Ruth McPherson; Christa Meisinger; David Melzer; David Meyre; Braxton D Mitchell; Mario A Morken; Sutapa Mukherjee; Silvia Naitza; Narisu Narisu; Matthew J Neville; Ben A Oostra; Marco Orrù; Ruth Pakyz; Colin N A Palmer; Giuseppe Paolisso; Cristian Pattaro; Daniel Pearson; John F Peden; Nancy L Pedersen; Markus Perola; Andreas F H Pfeiffer; Irene Pichler; Ozren Polasek; Danielle Posthuma; Simon C Potter; Anneli Pouta; Michael A Province; Bruce M Psaty; Wolfgang Rathmann; Nigel W Rayner; Kenneth Rice; Samuli Ripatti; Fernando Rivadeneira; Michael Roden; Olov Rolandsson; Annelli Sandbaek; Manjinder Sandhu; Serena Sanna; Avan Aihie Sayer; Paul Scheet; Laura J Scott; Udo Seedorf; Stephen J Sharp; Beverley Shields; Gunnar Sigurethsson; Eric J G Sijbrands; Angela Silveira; Laila Simpson; Andrew Singleton; Nicholas L Smith; Ulla Sovio; Amy Swift; Holly Syddall; Ann-Christine Syvänen; Toshiko Tanaka; Barbara Thorand; Jean Tichet; Anke Tönjes; Tiinamaija Tuomi; André G Uitterlinden; Ko Willems van Dijk; Mandy van Hoek; Dhiraj Varma; Sophie Visvikis-Siest; Veronique Vitart; Nicole Vogelzangs; Gérard Waeber; Peter J Wagner; Andrew Walley; G Bragi Walters; Kim L Ward; Hugh Watkins; Michael N Weedon; Sarah H Wild; Gonneke Willemsen; Jaqueline C M Witteman; John W G Yarnell; Eleftheria Zeggini; Diana Zelenika; Björn Zethelius; Guangju Zhai; Jing Hua Zhao; M Carola Zillikens; Ingrid B Borecki; Ruth J F Loos; Pierre Meneton; Patrik K E Magnusson; David M Nathan; Gordon H Williams; Andrew T Hattersley; Kaisa Silander; Veikko Salomaa; George Davey Smith; Stefan R Bornstein; Peter Schwarz; Joachim Spranger; Fredrik Karpe; Alan R Shuldiner; Cyrus Cooper; George V Dedoussis; Manuel Serrano-Ríos; Andrew D Morris; Lars Lind; Lyle J Palmer; Frank B Hu; Paul W Franks; Shah Ebrahim; Michael Marmot; W H Linda Kao; James S Pankow; Michael J Sampson; Johanna Kuusisto; Markku Laakso; Torben Hansen; Oluf Pedersen; Peter Paul Pramstaller; H Erich Wichmann; Thomas Illig; Igor Rudan; Alan F Wright; Michael Stumvoll; Harry Campbell; James F Wilson; Richard N Bergman; Thomas A Buchanan; Francis S Collins; Karen L Mohlke; Jaakko Tuomilehto; Timo T Valle; David Altshuler; Jerome I Rotter; David S Siscovick; Brenda W J H Penninx; Dorret I Boomsma; Panos Deloukas; Timothy D Spector; Timothy M Frayling; Luigi Ferrucci; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson; Cornelia M van Duijn; Yurii S Aulchenko; Antonio Cao; Angelo Scuteri; David Schlessinger; Manuela Uda; Aimo Ruokonen; Marjo-Riitta Jarvelin; Dawn M Waterworth; Peter Vollenweider; Leena Peltonen; Vincent Mooser; Goncalo R Abecasis; Nicholas J Wareham; Robert Sladek; Philippe Froguel; Richard M Watanabe; James B Meigs; Leif Groop; Michael Boehnke; Mark I McCarthy; Jose C Florez; Inês Barroso
Journal:  Nat Genet       Date:  2010-01-17       Impact factor: 38.330

View more
  10 in total

1.  Identification and functional characterisation of novel glucokinase mutations causing maturity-onset diabetes of the young in Slovakia.

Authors:  Lucia Valentínová; Nicola L Beer; Juraj Staník; Nicholas D Tribble; Martijn van de Bunt; Miroslava Hučková; Amy Barrett; Iwar Klimeš; Daniela Gašperíková; Anna L Gloyn
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

2.  Insights into the pathogenicity of rare missense GCK variants from the identification and functional characterization of compound heterozygous and double mutations inherited in cis.

Authors:  Nicola L Beer; Kara K Osbak; Martijn van de Bunt; Nicholas D Tribble; Anna M Steele; Kirsty J Wensley; Emma L Edghill; Kevin Colcough; Amy Barrett; Lucia Valentínová; Jana K Rundle; Anne Raimondo; Joseph Grimsby; Sian Ellard; Anna L Gloyn
Journal:  Diabetes Care       Date:  2012-05-18       Impact factor: 19.112

3.  Reclassification of diabetes etiology in a family with multiple diabetes phenotypes.

Authors:  Fotini K Kavvoura; Anne Raimondo; Gayathiry Thanabalasingham; Amy Barrett; Amanda L Webster; Debbie Shears; Nicholas P Mann; Sian Ellard; Anna L Gloyn; Katharine R Owen
Journal:  J Clin Endocrinol Metab       Date:  2014-02-27       Impact factor: 5.958

4.  Glucokinase mutation-a rare cause of recurrent hypoglycemia in adults: a case report and literature review.

Authors:  Oluremi N Ajala; David M Huffman; Ibrahim I Ghobrial
Journal:  J Community Hosp Intern Med Perspect       Date:  2016-10-26

5.  Clinical and enzymatic phenotypes in congenital hyperinsulinemic hypoglycemia due to glucokinase-activating mutations: A report of two cases and a brief overview of the literature.

Authors:  Fan Ping; Zhixin Wang; Xinhua Xiao
Journal:  J Diabetes Investig       Date:  2019-06-12       Impact factor: 4.232

Review 6.  The insulin centennial-100 years of milestones in biochemistry.

Authors:  Alan D Attie; Qi-Qun Tang; Karin E Bornfeldt
Journal:  J Lipid Res       Date:  2021-10-28       Impact factor: 5.922

7.  The novel GCK variant p.Val455Leu associated with hyperinsulinism is susceptible to allosteric activation and is conducive to weight gain and the development of diabetes.

Authors:  Sara Langer; Rica Waterstradt; Georg Hillebrand; René Santer; Simone Baltrusch
Journal:  Diabetologia       Date:  2021-09-16       Impact factor: 10.122

8.  Hyperinsulinemic Hypoglycemia in Three Generations of a Family with Glucokinase Activating Mutation, c.295T>C (p.Trp99Arg).

Authors:  Aleksandra Gilis-Januszewska; Anna Bogusławska; Artur Kowalik; Ewelina Rzepka; Karolina Soczówka; Elwira Przybylik-Mazurek; Bogusław Głowa; Alicja Hubalewska-Dydejczyk
Journal:  Genes (Basel)       Date:  2021-10-01       Impact factor: 4.096

9.  Familial adult onset hyperinsulinism due to an activating glucokinase mutation: implications for pharmacological glucokinase activation.

Authors:  Benjamin G Challis; Julie Harris; Alison Sleigh; Iona Isaac; Steve M Orme; Nandini Seevaratnam; Ketan Dhatariya; Helen L Simpson; Robert K Semple
Journal:  Clin Endocrinol (Oxf)       Date:  2014-07-02       Impact factor: 3.478

10.  Recognition of maturity-onset diabetes of the young in China.

Authors:  Hua Liang; Yanan Zhang; Maixinyue Li; Jinhua Yan; Daizhi Yang; Sihui Luo; Xueying Zheng; Guoqing Yang; Zhuo Li; Wen Xu; Leif Groop; Jianping Weng
Journal:  J Diabetes Investig       Date:  2020-09-09       Impact factor: 4.232

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.